INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,592 Cr | ₹1,329 Cr | ₹748 Cr | ₹612 Cr | ₹404 Cr |
What is the latest Total Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,592 Cr |
| Mar2024 | ₹1,329 Cr |
| Mar2023 | ₹748 Cr |
| Mar2022 | ₹612 Cr |
| Mar2021 | ₹404 Cr |
How is Total Liabilities of INNOVA CAPTAB Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,592 Cr | 19.72 | |
| Mar2024 | ₹1,329 Cr | 77.68 | |
| Mar2023 | ₹748 Cr | 22.22 | |
| Mar2022 | ₹612 Cr | 51.35 | |
| Mar2021 | ₹404 Cr | - | |
Compare Total Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,882.2 Cr | 0.2% | 5.2% | -17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 0.2% |
5.2% |
-17.8% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses